Nathaniel Calloway - 09 Jan 2023 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Rebecca Hilt
Issuer symbol
LFCR
Transactions as of
09 Jan 2023
Net transactions value
$0
Form type
4
Filing time
11 Jan 2023, 15:21:39 UTC
Previous filing
02 Nov 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Unit Award +5,906 5,906 09 Jan 2023 Common Stock 5,906 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.